Remote photoplethysmography provides robust heart rate estimation but shows limited reliability for HRV and PRV
Remote Heart Rate Monitoring Shows Promise for Tracking Anxiety
This scoping review of 20 empirical studies evaluates the physiological validity of remote photoplethysmography (rPPG) for monitoring stress…
New research explores how remote heart rate monitoring can track stress and mental workload, though movement and lighting can affect accurac…
High-risk APOL1 genotypes more than double odds of lupus nephritis ESRD
High Risk APOL1 Genotypes Linked to Kidney Damage in Lupus
This meta-analysis of 1,885 patients of African ancestry with systemic lupus erythematosus found that high-risk APOL1 genotypes were associa…
A specific genetic marker called APOL1 may signal an increased risk of end-stage renal disease for patients with lupus and kidney involvemen…
Five pathways drive sepsis-induced cardiomyopathy; imaging and biomarker panels improve early diagnosis
New Strategies for Managing Sepsis Induced Heart Damage
This systematic review synthesizes current knowledge on sepsis-induced cardiomyopathy (SIC), identifying five major pathological pathways th…
Newer imaging tools and biomarker panels help doctors identify heart damage from sepsis earlier to move toward more precise, targeted treatm…
FDA Approves Lidocaine Hydrochloride Injection for Ventricular Arrhythmias
FDA approves lidocaine injection for emergency heart rhythm problems.
The FDA has approved Lidocaine Hydrochloride Injection for the acute management of ventricular arrhythmias, including those occurring during…
The FDA has approved a preservative-free form of lidocaine injection to treat dangerous heart rhythms that can occur during heart surgery or…
FDA Approves Lerochol (lerochol) for Hypercholesterolemia to Reduce LDL-C
FDA approves new monthly shot Lerochol to lower cholesterol
The FDA approved Lerochol (lerochol) as an adjunct to diet and exercise to reduce LDL-C in adults with hypercholesterolemia, including HeFH.…
The FDA approved Lerochol, a monthly injection, to lower LDL cholesterol in adults with high cholesterol. It is for people who need extra ch…
Eight traditional Chinese medicine injections combined with conventional medicine improve outcomes in post-AMI heart failure
Comparing Different Traditional Chinese Medicine Injections for Heart Failure Recovery
This systematic review and network meta-analysis of 62 RCTs involving 5922 participants evaluated eight traditional Chinese medicine injecti…
New research looks at how different herbal injections can help patients recover from heart attacks when used with standard medicine.
AI agent systems may improve cardiovascular outcomes and clinical documentation efficiency in heart failure
Artificial intelligence tools may improve outcomes for heart failure patients
This narrative review explores AI agent systems, including multi-agent architectures and digital twins, for managing heart failure. It highl…
New research shows AI systems can help manage complex heart data and potentially lower mortality rates for people with heart failure.
Traditional Chinese medicine integrated with cardiac rehabilitation addresses inflammation, autonomic dysfunction, and psychological disorders
Traditional Chinese medicine may help patients recover from heart attacks
This narrative review examines the integration of Traditional Chinese medicine (TCM) into cardiac rehabilitation for patients with cardiovas…
Integrating Traditional Chinese medicine with standard cardiac rehab could help manage inflammation and stress after heart surgery or a hear…
Genetic risk scores for Primary Aldosteronism identify blood pressure independent pathways for cardiovascular disease
Genetic Markers Linked to Heart Health in High Blood Pressure
This meta-analysis identifies 19 genetic loci associated with Primary Aldosteronism, including 13 new loci. The analysis suggests that a sub…
New research identifies 19 genetic markers for Primary Aldosteronism, showing how certain genes may impact heart health independently of blo…
Ticagrelor and prasugrel show no statistically credible difference in 1-year MACE for ACS patients
Comparing Ticagrelor and Prasugrel for Patients with Heart Conditions After Surgery
This meta-analysis of retrospective new-user cohort studies analyzed 133,718 adults with acute coronary syndrome undergoing first PCI. The s…
A large study compared two heart medications to see which was safer and more effective for patients after a heart procedure.
Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA
Dual antiplatelet therapy shows survival benefits for MINOCA patients
This meta-analysis of 13027 patients with myocardial infarction with nonobstructive coronary artery disease (MINOCA) found that dual antipla…
New data suggests that dual antiplatelet therapy may help reduce the risk of death in patients with a specific type of heart attack.
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
Intracoronary Thrombolysis Linked to Lower Risks After Heart Attack
This meta-analysis evaluated the impact of adjunctive intracoronary thrombolysis during primary percutaneous coronary intervention for patie…
Adding intracoronary thrombolysis during heart procedures may lower the risk of major complications and improve blood flow for patients with…